Do Evidence Review Groups Bias NICE Decisions?
Please complete the form below to view the webinar recording.
Evidence Review Groups (ERGs) are independent academic organizations commissioned by NICE to act objectively, but how much influence do they have on reimbursement decisions and cost-effectiveness assessments?
This webinar explores the potential bias and policy / industry implications:
- If ERGs are supposed to be independent and objective, will there be differences among the groups?
- Do ERGs cover different therapeutic areas?
- Are there different rates of positive decisions between the ERGs?
- Are some ERGs more critical of the economic evidence?